{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:41:21Z","timestamp":1773297681076,"version":"3.50.1"},"reference-count":38,"publisher":"American Physiological Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Applied Physiology"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:p> Na<jats:sup>+<\/jats:sup>\/H<jats:sup>+<\/jats:sup> exchanger (NHE-1) inhibition was demonstrated to induce the regression of cardiac hypertrophy (CH) in several experimental models and to inhibit mitochondrial death pathway in \u201cin-vitro\u201d experiments. Since recent reports show that NHE-1 inhibition delays the transition from CH to failure, and apoptosis plays a key role in this process, we investigated the effect of chronic treatment with the NHE-1 blocker cariporide on CH and apoptosis in the SHR. One month of cariporide treatment (30 mg\u00b7kg<jats:sup>\u22121<\/jats:sup>\u00b7day<jats:sup>\u22121<\/jats:sup>) induced the regression of CH (cardiomyocyte cross-sectional area: 468 \u00b1 20 vs. 285 \u00b1 9 \u03bcm<jats:sup>2<\/jats:sup> in untreated and cariporide-treated spontaneously hypertensive rats; P &lt; 0.05). Apoptosis was assessed by TUNEL staining, the expression of Bcl-2, Bax, and activation of caspase-3 and PARP-1 by immunoblot. Cariporide treatment decreased the TUNEL-positive cells, the Bax-to-Bcl-2 ratio (3.16 \u00b1 0.32 vs. 1.70 \u00b1 0.17, untreated and cariporide-treated, respectively; P &lt; 0.05); caspase-3 and PARP-1 activation (465 \u00b1 62 vs. 260 \u00b1 22 and 2,239 \u00b1 62 vs. 1,683 \u00b1 85 AU, untreated and cariporide-treated, respectively; P &lt; 0.05). Angiotensin II, a growth factor and apoptotic stimulus, was used to induce O<jats:sub>2<\/jats:sub><jats:sup>\u2212<\/jats:sup> production that activated the ERK1\/2-p90<jats:sup>RSK<\/jats:sup> pathway, increasing NHE-1 phosphorylation. These effects were prevented by losartan, N-(2-mercaptopropionyl)-glycine, and cariporide. In conclusion, we present data demonstrating that chronic NHE-1 inhibition with cariporide decreases both hypertrophy and apoptosis susceptibility in the spontaneously hypertensive rat heart. The antiapoptotic effect would be the consequence of two different actions of cariporide: the prevention of cytosolic Na<jats:sup>+<\/jats:sup> and Ca<jats:sup>2+<\/jats:sup> overload due to the inhibition of the sarcolemmal NHE-1 and a direct mitochondrial effect preventing mitochondrial permeability transition pore opening. <\/jats:p>","DOI":"10.1152\/japplphysiol.91300.2008","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T02:48:41Z","timestamp":1233283721000},"page":"1325-1331","source":"Crossref","is-referenced-by-count":32,"title":["Chronic NHE-1 blockade induces an antiapoptotic effect in the hypertrophied heart"],"prefix":"10.1152","volume":"106","author":[{"given":"Carolina D.","family":"Garciarena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia I.","family":"Caldiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique L.","family":"Portiansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladys E.","family":"Chiappe de Cingolani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene L.","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1322"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.04.014"},{"key":"R3","unstructured":"Alvarez BV, Ennis IL, De Hurtado MC, Cingolani HE. Effects of antihypertensive therapy on cardiac sodium\/hydrogen ion exchanger activity and hypertrophy in spontaneously hypertensive rats. Can J Cardiol 18: 667\u2013672, 2002."},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.189"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00848-9"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00809-X"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.09.024"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2007.141689"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00544-2"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2004.12.011"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000051502.93374.1C"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1997.0561"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.30.5.1029"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.4.961"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1139\/y06-072"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.32.2.280"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.90616.2008"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(03)00498-X"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.143.1.207"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1007\/s004240000512"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1042\/BST0340232"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.26.4.642"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2004.10.007"},{"key":"R24","unstructured":"Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976\u20133985, 1993."},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1997.272.5.H2313"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.7.1506"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1161\/hh1201.093159"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1007\/BF03086178"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1159\/000046888"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.77.6.1192"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2004.11.003"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00864.2002"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2828(95)90128-0"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.76.5.825"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M600268200"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2003.12.016"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000093277.20968.C7"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.02.013"}],"container-title":["Journal of Applied Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/japplphysiol.91300.2008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T21:38:13Z","timestamp":1567978693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/japplphysiol.91300.2008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1152\/japplphysiol.91300.2008"],"URL":"https:\/\/doi.org\/10.1152\/japplphysiol.91300.2008","relation":{},"ISSN":["8750-7587","1522-1601"],"issn-type":[{"value":"8750-7587","type":"print"},{"value":"1522-1601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}